Macro
Search catalysts, news stories, and pressures, or browse the trust-weighted news feed below.
Home
tech
energy
finance
healthcare
defense
industrial
consumer
communication
utilities
real estate
raw materials
← back
healthcare · sector mood
1980
year mood
+0.21
· +0.10 to +0.50 across 12 mo
Monthly mood
bearish −1
+1 bullish
month values ▾
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0.10 | +0.10 | +0.10 | +0.10 | +0.10 | +0.10 | +0.20 | +0.20 | +0.20 | +0.30 | +0.50 | +0.50 |
Reagan wins on deregulation platform; pharma optimism
How this mood is scored ▾
Each day the model reads that day's news for the sector and asks, as someone who owns assets or
makes their living in it: how am I feeling this month, and why?
The month's mood is that running answer, tied to the specific events driving it (the story shown
above). It leans on trusted, higher-impact reporting, and on the prior month when a month is
quiet, so one loud headline can't swing it. The read updates daily through
the month; once a month ends, its mood is locked.
This year is read live from the news the pipeline actually collected (hover a bar for its story count).
· last computed Jul 06, 2026
Top healthcare stories of 1980
Oct
Genentech IPO soars, then cools amid biotech frenzy
upi.com →
Genentech's IPO ignited Wall Street, with shares jumping from $35 to $89 in minutes before settling at $56 by week's end, driven by speculative excitement over genetic engineering's potential. The 4-year-old biotech firm, backed by promise in recombinant DNA technology, saw massive demand despite minimal earnings, highlighting investor faith over fundamentals. Market volatility and SEC scrutiny underscored concerns about valuation and potential manipulation, signaling both opportunity and risk in the emerging biotech sector.